Cancer Family
Malignant Digestive System Neoplasm
CI-CAN-00000229Explore in graph →
4,262 active trials43 approved drugs556 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000229Explore in graph →
Clinical trials
19,108 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (2,001)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00991003 | A New Method for Colorectal Cancer Screening: Colon Capsule Endoscopy Compared to Conventional Endoscopy | completed | N/A | 59 | University Hospital, Basel, SwitzerlandOTHER | 1 | Oct 7, 2009 | clinicaltrials |
| NCT00447967 | Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients | completed | Phase 2 | 110 | Hellenic Oncology Research GroupOTHER | 1 | Sep 28, 2009 | clinicaltrials |
| NCT00465725 | A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors | completed | Phase 1 | 18 | Poniard PharmaceuticalsINDUSTRY | 1 | Sep 24, 2009 | clinicaltrials |
| NCT00980603 | Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric Cancer | unknown | Phase 2 | 144 | National Cancer Center, KoreaOTHER_GOV | 1 | Sep 21, 2009 | clinicaltrials |
| NCT00625573 | Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01)(ABX067) | completed | Phase 2 | 29 | Mt. Sinai Medical Center, MiamiOTHER | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00853684 | Oxaliplatin, Capecitabine and Endostar as First Line Treatment for Patients With Advanced Colorectal Cancer(OXCE) | unknown | Phase 2 | 44 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00280618 | Oxaliplatin in Unresectable Hepatocellular Carcinoma | completed | Phase 2 | — | SanofiINDUSTRY | 0 | Sep 15, 2009 | clinicaltrials |
| NCT00327119 | Phase 2 Study of ABX-EGF (Panitumumab) in Japanese Subjects With M-colorectal Cancer | completed | Phase 2 | 50 | AmgenINDUSTRY | 0 | Sep 14, 2009 | clinicaltrials |
| NCT00973713 | Study of RAD001 in Advanced Cholangiocarcinoma: RADiChol(RADiChol) | unknown | Phase 2 | 27 | Austin HealthOTHER_GOV | 1 | Sep 9, 2009 | clinicaltrials |
| NCT00972465 | Study of Nimotuzumab to Treat Colorectal Cancer | unknown | Phase 2 | 48 | Peking UniversityOTHER | 1 | Sep 7, 2009 | clinicaltrials |
| NCT00630240 | Risk Factors for the Leakage of Anticancer Drugs to Systemic Circulation by Transcatheter Arterial Chemoembolization | completed | — | 53 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Sep 1, 2009 | clinicaltrials |
| NCT00964457 | Treatment of Patients With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before, Under and After Radiation and With Adding Cetuximab to K-RAS Wild-type Patients | unknown | Phase 2 | 60 | Copenhagen University Hospital at HerlevOTHER | 1 | Aug 25, 2009 | clinicaltrials |
| NCT00963794 | Diagnosis of Rectal Cancer by Electromagnetic Device | completed | N/A | 442 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Aug 24, 2009 | clinicaltrials |
| NCT00496704 | Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With Irinotecan | unknown | Phase 1 / Phase 2 | 56 | Yonsei UniversityOTHER | 1 | Aug 21, 2009 | clinicaltrials |
| NCT00961077 | Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric Cancer | unknown | Phase 2 | 36 | Soonchunhyang University HospitalOTHER | 0 | Aug 18, 2009 | clinicaltrials |
| NCT00495846 | GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma(SS-HCC) | completed | Phase 2 / Phase 3 | 25 | Federico II UniversityOTHER | 1 | Aug 17, 2009 | clinicaltrials |
| NCT00960518 | TACE and Adefovir Compared With Transarterial Chemoembolization (TACE) Alone for Hepatitis B Virus (HBV)-Related Unresectable Hepatocellular Carcinoma (HCC)(TACE) | unknown | Phase 2 | 216 | Tongji UniversityOTHER | 1 | Aug 17, 2009 | clinicaltrials |
| NCT00539318 | Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers | terminated | — | 60 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 14, 2009 | clinicaltrials |
| NCT00195572 | Study Evaluating Isovorin in Advanced/Recurrent Gastric Cancer | completed | Phase 3 | 200 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Aug 13, 2009 | clinicaltrials |
| NCT00195585 | Study Evaluating Isovorin in Colon Cancer | completed | Phase 3 | 650 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Aug 13, 2009 | clinicaltrials |
| NCT00956241 | J-pouch Versus Side-to-end Coloanal Anastomosis After Preoperative Radiotherapy and Total Mesorectal Excision for Rectal Cancer | completed | N/A | 127 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Aug 11, 2009 | clinicaltrials |
| NCT00307723 | Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer | terminated | Phase 1 / Phase 2 | 52 | Massachusetts General HospitalOTHER | 0 | Aug 10, 2009 | clinicaltrials |
| NCT00513266 | Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery | unknown | Phase 2 | 35 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Aug 7, 2009 | clinicaltrials |
| NCT00197405 | Comparison of Fecal Ribonucleic Acid (RNA) Test With Fecal Occult Blood Test (FOBT) for Detecting Colorectal Cancer and Adenoma | unknown | — | 400 | Hamamatsu UniversityOTHER | 1 | Aug 4, 2009 | clinicaltrials |
| NCT00769730 | Evaluation the Possible Influence of Transcatheter Arterial Chemoembolization on Hepatitis B Viral Replication | completed | — | 25 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Aug 4, 2009 | clinicaltrials |
| NCT00622804 | Comparison Study for Bile Reflux and Gastric Stasis in Patients After Distal Gastrectomy | withdrawn | Phase 3 | 90 | The Catholic University of KoreaOTHER | 1 | Aug 3, 2009 | clinicaltrials |
| NCT00945568 | Preoperative Oral Supplementation With Branched-Chain Amino Acids (BCAA) Improves Postoperative Quality of Life(KMS) | completed | N/A | 100 | Kochi UniversityOTHER | 1 | Jul 24, 2009 | clinicaltrials |
| NCT00436514 | Colonoscopy by Videocapsuls Versus Standard Colonoscopy. Intra-individual Comparison for the Subject With a Medium or High Risk of Colorectal Cancer. | completed | N/A | 550 | Nantes University HospitalOTHER | 1 | Jul 23, 2009 | clinicaltrials |
| NCT00906802 | Benefit of Roux-en-Y (R-Y) Reconstruction After Pancreaticoduodenectomy | unknown | N/A | 40 | Kochi UniversityOTHER | 1 | Jul 23, 2009 | clinicaltrials |
| NCT00942461 | Inflammatory Response in Laparoscopic and Open Colectomy | completed | Phase 4 | 40 | G. Hatzikosta General HospitalOTHER | 1 | Jul 21, 2009 | clinicaltrials |
| NCT00350753 | Avastin and Tarceva for Upper Gastrointestinal Cancers | completed | Phase 2 | 126 | Rigshospitalet, DenmarkOTHER | 1 | Jul 15, 2009 | clinicaltrials |
| NCT00107861 | Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases | completed | Phase 1 / Phase 2 | 44 | BiogenINDUSTRY | 1 | Jul 14, 2009 | clinicaltrials |
| NCT00598546 | Quality of Life Among Long-Term Survivors of Resected Gastric Cancer | completed | — | 212 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 10, 2009 | clinicaltrials |
| NCT00936572 | Probiotics In Colorectal Cancer Patients | completed | Phase 2 | 35 | University of Milano BicoccaOTHER | 1 | Jul 10, 2009 | clinicaltrials |
| NCT00884767 | Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin | unknown | Phase 2 | 206 | Institut Cancerologie de l'OuestOTHER | 1 | Jul 8, 2009 | clinicaltrials |
| NCT00464919 | Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 50 | National Taiwan University HospitalOTHER | 1 | Jul 7, 2009 | clinicaltrials |
| NCT00595985 | Sorafenib as a Second Line Treatment in Patients With Advanced or Metastatic Gastric Cancer | terminated | Phase 2 | 5 | Fudan UniversityOTHER | 1 | Jul 7, 2009 | clinicaltrials |
| NCT00644254 | The Prognostic Impact of Extracapsular Lymph Node Involvement in Ductal Pancreatic Adenocarcinoma(ECLNI DPAC) | completed | — | 145 | KU LeuvenOTHER | 1 | Jul 7, 2009 | clinicaltrials |
| NCT00390195 | Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC) | unknown | Phase 1 / Phase 2 | 134 | National Health Research Institutes, TaiwanOTHER | 1 | Jul 2, 2009 | clinicaltrials |
| NCT00928928 | Oxidative Stress Markers in Open and Laparoscopic Colectomy for Cancer | completed | Phase 4 | 40 | G. Hatzikosta General HospitalOTHER | 1 | Jun 26, 2009 | clinicaltrials |
| NCT00786058 | A Phase III Second Line Trial in Advanced Pancreatic Cancer CONKO 003 | approved for marketing | — | — | CONKO-StudiengruppeOTHER | 0 | Jun 15, 2009 | clinicaltrials |
| NCT00919282 | Gemcitabine (GFF) in Patients With Pancreatic Cancer(GFF) | completed | Phase 2 | 78 | CONKO-StudiengruppeOTHER | 1 | Jun 12, 2009 | clinicaltrials |
| NCT00919659 | Parenteral Nutrition Support for Patients With Pancreatic Cancer | completed | Phase 2 | 32 | CONKO-StudiengruppeOTHER | 1 | Jun 12, 2009 | clinicaltrials |
| NCT00498407 | A Phase II Study of CP-4055 as Second Line Therapy in Patients With Advanced Colorectal Cancer | completed | Phase 2 | 16 | Clavis PharmaINDUSTRY | 1 | Jun 4, 2009 | clinicaltrials |
| NCT00288925 | Z-360 in Unresectable Advanced Pancreatic Cancer in Combination With Gemcitabine Treatment | completed | Phase 1 / Phase 2 | 30 | Zeria PharmaceuticalINDUSTRY | 1 | Jun 1, 2009 | clinicaltrials |
| NCT00910143 | Introduction and Influence of Total Mesorectal Excision (TME) in the Treatment of Rectal Cancer | completed | — | 194 | Insel Gruppe AG, University Hospital BernOTHER | 1 | May 29, 2009 | clinicaltrials |
| NCT00854854 | Efficacy Study of TKcell in Advanced Gastric Cancer | unknown | Phase 1 / Phase 2 | 94 | BinexINDUSTRY | 1 | May 18, 2009 | clinicaltrials |
| NCT00854971 | Efficacy Study of TKcell in Advanced Colorectal Cancer | unknown | Phase 1 / Phase 2 | 86 | BinexINDUSTRY | 1 | May 18, 2009 | clinicaltrials |
| NCT00902902 | A Clinical Study of GP73 as a Hepatocellular Carcinoma (HCC) Tumor Mark | unknown | — | 0 | Peking Union Medical College HospitalOTHER | 1 | May 15, 2009 | clinicaltrials |
| NCT00683358 | Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer | unknown | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | May 7, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Oct 7, 2009source: clinicaltrials